Additionally, the main intra-tumoral T cell profiles were compatible with effector memory T cell and terminal effector memory T cell phenotypes in the CD8+ T cell compartment, potentially indicating their cytotoxic activity against cancer cells and contributing to anti-tumor immune responses despite a lack of histologic response to therapy (Figure 3H). The gene discussed is CD8A; the disease is neoplasm.